TY - JOUR
T1 - Fast prediction of cytochrome P450 mediated drug metabolism
AU - Rydberg, P.
AU - Vasanthanathan, P.
AU - Oostenbrink, C.
AU - Olsen, L.
PY - 2009
Y1 - 2009
N2 - Cytochrome P450 mediated metabolism of drugs is one of the major determinants of their kinetic profile, and prediction of this metabolism is therefore highly relevant during the drug discovery and development process. A new rule-based method, based on results from density functional theory calculations, for predicting activation energies for aliphatic and aromatic oxidations by cytochromes P450 is developed and compared with several other methods. Although the applicability of the method is currently limited to a subset of P450 reactions, these reactions describe more than 90% of the metabolites. The rules employed are relatively few and general, and when combined with solvent-accessible surface area calculations to account for steric accessibility, the method gives a major P450 metabolite as first-ranked position for 75% of the substrates, and ranked in the top three for 90% of substrates for a set of 20 substrates. In combination with docking, it can predict isoform-specific metabolism, and we apply this on CYP1A2 with very good results on 81 substrates, for which we find a major metabolite ranked in the top three for 90% of the substrates (100% in the training set and 87% in the larger test set). © 2009 Wiley-VCH Verlag GmbH & Co. KGaA.
AB - Cytochrome P450 mediated metabolism of drugs is one of the major determinants of their kinetic profile, and prediction of this metabolism is therefore highly relevant during the drug discovery and development process. A new rule-based method, based on results from density functional theory calculations, for predicting activation energies for aliphatic and aromatic oxidations by cytochromes P450 is developed and compared with several other methods. Although the applicability of the method is currently limited to a subset of P450 reactions, these reactions describe more than 90% of the metabolites. The rules employed are relatively few and general, and when combined with solvent-accessible surface area calculations to account for steric accessibility, the method gives a major P450 metabolite as first-ranked position for 75% of the substrates, and ranked in the top three for 90% of substrates for a set of 20 substrates. In combination with docking, it can predict isoform-specific metabolism, and we apply this on CYP1A2 with very good results on 81 substrates, for which we find a major metabolite ranked in the top three for 90% of the substrates (100% in the training set and 87% in the larger test set). © 2009 Wiley-VCH Verlag GmbH & Co. KGaA.
U2 - 10.1002/cmdc.200900363
DO - 10.1002/cmdc.200900363
M3 - Article
SN - 1860-7179
VL - 4
SP - 2070
EP - 2079
JO - ChemMedChem
JF - ChemMedChem
IS - 12
ER -